HOW THE PHARMACEUTICAL SECTOR IS EMBRACING SUSTAINABILITY

Nav Rattan is a visionary leader driving business growth for Ind-Swift Group both in India and Internationally. He is also a Philanthropist and has held key industry positions, including Ex-Chairman of the Pharmaceutical Export Promotion Council of India and Ex-President of the Indian Drugs Manufacturers' Association, IDMA. Also, he works on boards including the Ministries of Commerce & Industry and National Institute of Pharmaceutical Education and Research (NIPER).

- Nav Rattan Munjal, Chairman & Managing Director, Ind-Swift Group

India's pharmaceutical landscape has evolved rapidly, transforming into a global manufacturing hub with significant exports, especially in generics and vaccines. Indian pharmaceutical companies are increasingly prioritizing sustainable practices due to growing regulatory pressures, global demands, and environmental awareness. A sustainable stance across the sector involves reducing carbon footprints, minimizing water and energy usage, improving waste management, and adopting green chemistry. Emphasizing sustainability ensures compliance with global standards, reduces costs over the long term, and strengthens the sector's international reputation.

Strategies for Sustainability in Drug Development & Disposal

Leading pharmaceutical companies employ several strategies to embed sustainability throughout the drug lifecycle:

• Green Chemistry: Implementing environmentally friendly chemical processes to minimize waste and use safer solvents.

• Sustainable Supply Chain Management: Using suppliers that comply with environmental standards and reducing transportation emissions.

• Eco-Friendly Packaging: Reducing single-use plastics and opting for biodegradable, recyclable materials.